SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4acq'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1EE2_A_CHDA1150_1
(ALCOHOL
DEHYDROGENASE)
4acq ALPHA-2-MACROGLOBULI
N

(Homo
sapiens)
4 / 4 GLU A 160
MET A 151
LEU A 128
SER A 127
None
1.44A 1ee2B-4acqA:
undetectable
1ee2B-4acqA:
13.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GS4_A_ZK5A1918_1
(ANDROGEN RECEPTOR)
4acq ALPHA-2-MACROGLOBULI
N

(Homo
sapiens)
5 / 12 LEU A 828
GLN A 843
VAL A 839
ALA A 812
LEU A 796
None
1.18A 1gs4A-4acqA:
undetectable
1gs4A-4acqA:
10.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HA2_A_SWFA3001_1
(SERUM ALBUMIN)
4acq ALPHA-2-MACROGLOBULI
N

(Homo
sapiens)
5 / 11 ALA A 556
LEU A 540
LEU A 461
SER A 525
ILE A 526
None
1.04A 1ha2A-4acqA:
2.7
1ha2A-4acqA:
16.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1LIN_A_TFPA154_1
(CALMODULIN)
4acq ALPHA-2-MACROGLOBULI
N

(Homo
sapiens)
4 / 7 LEU A 920
MET A1314
GLU A 929
LEU A 931
None
1.08A 1linA-4acqA:
undetectable
1linA-4acqA:
8.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MJO_B_SAMB200_0
(METHIONINE REPRESSOR)
4acq ALPHA-2-MACROGLOBULI
N

(Homo
sapiens)
4 / 4 HIS A 479
ALA A 478
PHE A 524
GLY A 522
None
1.25A 1mjoA-4acqA:
undetectable
1mjoA-4acqA:
5.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1TV8_B_SAMB2501_0
(MOLYBDENUM COFACTOR
BIOSYNTHESIS PROTEIN
A)
4acq ALPHA-2-MACROGLOBULI
N

(Homo
sapiens)
4 / 7 THR A1232
THR A1229
SER A1225
VAL A 927
None
1.16A 1tv8B-4acqA:
undetectable
1tv8B-4acqA:
13.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1YA4_C_CTXC3_2
(CES1 PROTEIN)
4acq ALPHA-2-MACROGLOBULI
N

(Homo
sapiens)
4 / 4 LEU A1046
PRO A1119
ILE A1068
LEU A1070
None
1.01A 1ya4C-4acqA:
undetectable
1ya4C-4acqA:
17.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BXQ_A_IMNA2001_1
(SERUM ALBUMIN)
4acq ALPHA-2-MACROGLOBULI
N

(Homo
sapiens)
5 / 10 SER A1026
TRP A1069
ALA A1066
LEU A1067
LEU A1046
None
1.14A 2bxqA-4acqA:
undetectable
2bxqA-4acqA:
16.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FB2_B_SAMB501_0
(MOLYBDENUM COFACTOR
BIOSYNTHESIS PROTEIN
A)
4acq ALPHA-2-MACROGLOBULI
N

(Homo
sapiens)
4 / 7 THR A1232
THR A1229
SER A1225
VAL A 927
None
1.23A 2fb2B-4acqA:
undetectable
2fb2B-4acqA:
12.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YGN_A_PCFA1179_1
(WNT INHIBITORY
FACTOR 1)
4acq ALPHA-2-MACROGLOBULI
N

(Homo
sapiens)
4 / 5 ILE A 505
PHE A  89
VAL A  67
PHE A 678
None
1.17A 2ygnA-4acqA:
undetectable
2ygnA-4acqA:
8.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EM4_V_DR7V100_2
(PROTEASE)
4acq ALPHA-2-MACROGLOBULI
N

(Homo
sapiens)
5 / 10 ILE A 379
GLY A 403
LEU A 404
VAL A 421
ILE A 384
None
0.97A 3em4V-4acqA:
undetectable
3em4V-4acqA:
5.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N58_C_ADNC500_2
(ADENOSYLHOMOCYSTEINA
SE)
4acq ALPHA-2-MACROGLOBULI
N

(Homo
sapiens)
4 / 5 LEU A 931
GLN A1325
THR A1326
GLU A 929
None
1.44A 3n58C-4acqA:
undetectable
3n58C-4acqA:
15.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RUN_A_CCSA165_0
(LYSOZYME)
4acq ALPHA-2-MACROGLOBULI
N

(Homo
sapiens)
3 / 3 ASN A 566
ALA A 565
LYS A 567
None
0.89A 3runA-4acqA:
undetectable
3runA-4acqA:
8.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TYE_B_YTZB902_1
(DIHYDROPTEROATE
SYNTHASE)
4acq ALPHA-2-MACROGLOBULI
N

(Homo
sapiens)
3 / 3 PHE A 224
LYS A 135
SER A 136
None
1.22A 3tyeB-4acqA:
undetectable
3tyeB-4acqA:
11.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3V35_A_NTIA317_1
(ALDOSE REDUCTASE)
4acq ALPHA-2-MACROGLOBULI
N

(Homo
sapiens)
4 / 8 VAL A 355
HIS A 446
PHE A 407
PRO A 364
None
None
None
NAG  A2401 (-3.9A)
1.46A 3v35A-4acqA:
undetectable
3v35A-4acqA:
12.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A97_C_ZPCC1318_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)
4acq ALPHA-2-MACROGLOBULI
N

(Homo
sapiens)
5 / 12 PHE A 300
VAL A 266
ILE A 268
TYR A 301
VAL A 304
None
0.97A 4a97B-4acqA:
3.5
4a97C-4acqA:
3.5
4a97B-4acqA:
11.67
4a97C-4acqA:
11.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UCI_A_ADNA2414_1
(RNA-DIRECTED RNA
POLYMERASE L)
4acq ALPHA-2-MACROGLOBULI
N

(Homo
sapiens)
4 / 6 PHE A 365
ARG A 360
PHE A 359
HIS A 358
None
1.23A 4uciA-4acqA:
undetectable
4uciA-4acqA:
13.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)
4acq ALPHA-2-MACROGLOBULI
N

(Homo
sapiens)
4 / 7 PHE A 155
LEU A 778
SER A 532
VAL A 618
None
1.05A 4wnvD-4acqA:
undetectable
4wnvD-4acqA:
16.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5DZK_2_BEZ2801_0
(ATP-DEPENDENT CLP
PROTEASE PROTEOLYTIC
SUBUNIT 1
BEZ-LEU-LEU)
4acq ALPHA-2-MACROGLOBULI
N

(Homo
sapiens)
4 / 4 LEU A 468
ARG A 507
ILE A 528
ILE A 499
None
1.25A 5dzk2-4acqA:
undetectable
5dzkM-4acqA:
undetectable
5dzkN-4acqA:
undetectable
5dzk2-4acqA:
12.50
5dzkM-4acqA:
9.29
5dzkN-4acqA:
9.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5DZK_V_BEZV801_0
(ATP-DEPENDENT CLP
PROTEASE PROTEOLYTIC
SUBUNIT 1
BEZ-LEU-LEU)
4acq ALPHA-2-MACROGLOBULI
N

(Homo
sapiens)
4 / 4 ILE A 528
ILE A 499
ARG A 507
LEU A 468
None
1.19A 5dzkh-4acqA:
undetectable
5dzkn-4acqA:
undetectable
5dzkv-4acqA:
undetectable
5dzkh-4acqA:
9.29
5dzkn-4acqA:
9.29
5dzkv-4acqA:
12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5OEX_A_CUA602_0
(THIOCYANATE
DEHYDROGENASE)
4acq ALPHA-2-MACROGLOBULI
N

(Homo
sapiens)
3 / 3 LYS A 521
HIS A 523
HIS A 479
None
1.21A 5oexA-4acqA:
undetectable
5oexA-4acqA:
15.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5OEX_B_CUB602_0
(THIOCYANATE
DEHYDROGENASE)
4acq ALPHA-2-MACROGLOBULI
N

(Homo
sapiens)
3 / 3 LYS A 521
HIS A 523
HIS A 479
None
1.20A 5oexB-4acqA:
undetectable
5oexB-4acqA:
15.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5OEX_C_CUC603_0
(THIOCYANATE
DEHYDROGENASE)
4acq ALPHA-2-MACROGLOBULI
N

(Homo
sapiens)
3 / 3 LYS A 521
HIS A 523
HIS A 479
None
1.18A 5oexC-4acqA:
undetectable
5oexC-4acqA:
15.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5OEX_D_CUD603_0
(THIOCYANATE
DEHYDROGENASE)
4acq ALPHA-2-MACROGLOBULI
N

(Homo
sapiens)
3 / 3 LYS A 521
HIS A 523
HIS A 479
None
1.16A 5oexD-4acqA:
undetectable
5oexD-4acqA:
15.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B0I_B_TA1B502_1
(TUBULIN BETA CHAIN)
4acq ALPHA-2-MACROGLOBULI
N

(Homo
sapiens)
5 / 12 VAL A 551
ASP A 550
ASP A  82
GLY A 485
LEU A 482
None
1.08A 6b0iB-4acqA:
undetectable
6b0iB-4acqA:
4.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CK2_C_IPHC101_0
(INSULIN A CHAIN
INSULIN B CHAIN)
4acq ALPHA-2-MACROGLOBULI
N

(Homo
sapiens)
4 / 4 ILE A 528
LEU A 461
HIS A 511
ALA A 478
None
0.96A 6ck2C-4acqA:
undetectable
6ck2D-4acqA:
undetectable
6ck2C-4acqA:
2.61
6ck2D-4acqA:
2.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6GNG_B_QPSB601_1
(-)
4acq ALPHA-2-MACROGLOBULI
N

(Homo
sapiens)
5 / 12 THR A1268
VAL A1292
TYR A1264
VAL A1278
GLY A1318
None
1.43A 6gngB-4acqA:
undetectable
6gngB-4acqA:
18.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6GP2_B_DAHB126_0
(RIBONUCLEOSIDE-DIPHO
SPHATE REDUCTASE
BETA CHAIN)
4acq ALPHA-2-MACROGLOBULI
N

(Homo
sapiens)
5 / 11 PHE A 219
GLY A 201
PHE A 192
ILE A 167
ILE A 175
None
1.06A 6gp2B-4acqA:
undetectable
6gp2B-4acqA:
4.77